Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
- PMID: 33757805
- PMCID: PMC7979603
- DOI: 10.1016/j.jhep.2021.03.009
Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
Keywords: COVID-19; SARS-CoV2 vaccination; Viral hepatitis elimination; hepatitis C screening.
Conflict of interest statement
Conflict of interests All authors have nothing to declare. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Impact of COVID-19 on global HCV elimination efforts.J Hepatol. 2021 Jan;74(1):31-36. doi: 10.1016/j.jhep.2020.07.042. Epub 2020 Aug 7. J Hepatol. 2021. PMID: 32777322 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous